Should we Leave it to Patients to Identify Counterfeit Medicines?
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-V3I3-web-23.pdf
Continue Reading →
Current Edition
Current Edition
CDMO Subsection
Insights into the latest developments in CDMO services and manufacturing.
Continue readingInjectables Subsection
Expert perspectives on the evolving needs of injectable therapies and packaging.
Continue readingNasal & Pulmonary Subsection
Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability
Continue reading
Editorial Archive
The EU Directive Against Falsified Medicines and the Role of Security Labels
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-V3I3-web-22.pdf
Continue Reading →
Editorial Archive
Decentral Automation at all Process Levels Intelligent Control Heads Enable Complete Decentral Automation of Hygienic Production Processes
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-V3I3-web-21.pdf
Continue Reading →
Editorial Archive
Shedding Enhanced Light on Biological and Biomedical Systems
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-V3I3-web-20.pdf
Continue Reading →
Editorial Archive
Safeguarding the Global Pharmaceutical Supply Chain
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-19.pdf
Continue Reading →
Editorial Archive
Safely Transporting Clinical Trials through the Middle East
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-18.pdf
Continue Reading →
Clinical Research v3i3
Modernising Subject Payments in Clinical Trials
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-17.pdf
Continue Reading →
Clinical Research v3i3
Managing the Use of Research- Grade Kits During Clinical Trials
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-16.pdf
Continue Reading →
Clinical Research v3i3
Feasibility, Risk Management and Clinical Trials – Art or Science?
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-15.pdf
Continue Reading →
Clinical Research v3i3
Optimising Clinical Research Site Performance through Additive Patient Enrolment
https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-14.pdf
Continue Reading →
